600613 Shanghai Shenqi Pharmaceutical Investment Management
- 6.94
- -0.26-3.61%
Shanghai Shenqi Pharmaceutical Investment Management News
Written confirmation opinions of directors, supervisors and senior management of Shanghai Magic Pharmaceutical Investment Management Co., Ltd. on the company\'s report for the third quarter of 2024
Wonder Pharmaceuticals: Written Confirmation of the Company\'s 2024 Semi-Annual Report by Directors, Supervisors and Senior Management
Announcement of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. on the completion of industrial and commercial registration changes and the issuance of business license.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Legal Opinion of Beijing Deheng (Guiyang) Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Wonder Pharmaceuticals 2023 Annual Shareholders' Meeting Meeting Materials
Shanghai Magic Pharmaceutical Investment Management Co., Ltd. 2023 Internal Control Evaluation Report
Announcement of Shanghai Magic Pharmaceutical Investment Management Co., Ltd. on the calculation of impairment preparations for assets such as goodwill and transfer back credit impairment preparations
Shanghai Shenqi Pharmaceutical Investment Management: Special notes issued by supervisors on matters relating to the 5th meeting of the 11th Board of Supervisors
Announcement on the 2023 Profit Distribution Plan of Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Notice of Shanghai Magic Pharmaceutical Investment Management Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Shanghai Shenqi Pharmaceutical Investment Management: Report on the performance of the Audit Committee of the Board of Directors in 2023
Shanghai Shenqi Pharmaceutical Investment Management: Tianhua Asset Evaluation Report [2024] No. 10477 in the Pak Compulsory Drug Goodwill Impairment Test Evaluation Report
Shanghai Shenqi Pharmaceutical Investment Management: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms for the 2023 annual review
Shanghai Shenqi Pharmaceutical Investment Management: Tianhua Financial Assessment Report in the Binzhou Magical Goodwill Impairment Test Evaluation Report [2024] No. 10467
Announcement of Resolutions of the 2023 First Extraordinary General Meeting of Shareholders of Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Legal Opinion of Guizhou Qianli Law Firm on the 2023 First Extraordinary General Meeting of Shareholders of Shanghai Magic Pharmaceutical Investment Management Co., Ltd.
Miracle Pharmaceutical\'s 2023 First Extraordinary General Meeting of Shareholders Meeting Materials
Wonder Pharmaceuticals: Board of Directors Rules of Procedure (Revised in December 2023)
Wonder Pharmaceuticals: Rules of Work of the Special Committee of the Board of Directors (Revised in December 2023)
Analysis
Price Target
No Data
No Data